BioTime (NYSE:BTX) Insider William Phd Tew sold 13,860 shares of the stock in a transaction that occurred on Wednesday, November 20th. The shares were sold at an average price of $3.76, for a total value of $52,113.60. Following the sale, the insider now directly owns 33,265 shares in the company, valued at approximately $125,076. The sale was disclosed in a legal filing with the SEC, which is available at this link.
BioTime (NYSE:BTX) traded down 0.54% during mid-day trading on Wednesday, hitting $3.71. 77,024 shares of the company’s stock traded hands. BioTime has a 52 week low of $3.08 and a 52 week high of $5.02. The stock’s 50-day moving average is $3.76 and its 200-day moving average is $3.93. The company’s market cap is $206.4 million.
BioTime (NYSE:BTX) last issued its quarterly earnings data on Tuesday, November 12th. The company reported ($0.16) earnings per share (EPS) for the quarter.
BioTime, Inc is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (NYSE:BTX) cell lines, and royalties from Hextend.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.